United Therapeutics Corporation (UTHR)
USD 357.55
(-5.83%)
USD 357.55
(-5.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.32 Billion | 1.93 Billion | 1.68 Billion | 1.48 Billion | 1.44 Billion | 1.62 Billion |
| Cost of Revenue | 257.5 Million | 146.7 Million | 122.5 Million | 108.1 Million | 117.6 Million | 198.7 Million |
| Gross Profit | 2.07 Billion | 1.78 Billion | 1.56 Billion | 1.37 Billion | 1.33 Billion | 1.42 Billion |
| Operating Expenses | 885.1 Million | 809.9 Million | 1 Billion | 781.6 Million | 1.51 Billion | 623.7 Million |
| Selling, General and Administrative Expenses | 477.1 Million | 487 Million | 467 Million | 423.9 Million | 336.2 Million | 265.8 Million |
| Research and Development Expenses | 408 Million | 322.9 Million | 540.1 Million | 357.7 Million | 1.18 Billion | 357.9 Million |
| Other Expenses | - | -40.2 Million | 42.2 Million | 49.3 Million | 22.6 Million | -7.7 Million |
| Cost and Expenses | 1.14 Billion | 956.6 Million | 1.12 Billion | 889.7 Million | 1.63 Billion | 822.4 Million |
| Operating Income | 1.18 Billion | 979.7 Million | 555.9 Million | 593.6 Million | -187.6 Million | 805.4 Million |
| Interest Expense | 59.3 Million | 32.4 Million | 18.6 Million | 23.5 Million | 44.2 Million | 13.9 Million |
| Income Tax Expense | 289.5 Million | 223.3 Million | 118.1 Million | 124.1 Million | -60.5 Million | 169.7 Million |
| Earnings before Tax | 1.27 Billion | 950.6 Million | 593.9 Million | 638.9 Million | -165 Million | 758.9 Million |
| Net Income | 984.8 Million | 727.3 Million | 475.8 Million | 514.8 Million | -104.5 Million | 589.2 Million |
| Earnings Per Share Basic | 21.04 | 15.98 | 10.60 | 11.65 | -2.39 | 13.54 |
| Earnings Per Share Diluted | 19.81 | 15.00 | 10.06 | 11.54 | -2.39 | 13.39 |
| Weighted Average Shares Outstanding | 46.8 Million | 45.5 Million | 44.9 Million | 44.2 Million | 43.8 Million | 43.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 49.7 Million | 48.5 Million | 47.3 Million | 44.6 Million | 43.8 Million | 44 Million |
| Gross Margin | 0.89 | 0.92 | 0.93 | 0.93 | 0.92 | 0.88 |
| EBIT Margin | 0.60 | 0.51 | 0.36 | 0.45 | -0.08 | 0.51 |
| Profit Margin | 0.42 | 0.38 | 0.28 | 0.35 | -0.07 | 0.36 |
| EBITDA | 1.38 Billion | 1.04 Billion | 736.8 Million | 646.3 Million | -74.89 Million | 838.4 Million |
| Earnings Before Tax Margin | 0.51 | 0.51 | 0.33 | 0.40 | -0.13 | 0.49 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 748.9 Million | 714.9 Million | 677.7 Million | 614.7 Million | 2.32 Billion | 609.4 Million |
| Cost of Revenue | 83.1 Million | 77.8 Million | 72.9 Million | 71 Million | 257.5 Million | 70.1 Million |
| Gross Profit | 665.8 Million | 637.1 Million | 604.8 Million | 543.7 Million | 2.07 Billion | 539.3 Million |
| Operating Expenses | 257.6 Million | 317.2 Million | 248.5 Million | 283.6 Million | 885.1 Million | 212.3 Million |
| Selling, General and Administrative Expenses | 154.1 Million | 177.6 Million | 144.4 Million | 132.2 Million | - | 127.6 Million |
| Research and Development Expenses | 103.5 Million | 139.6 Million | 104.1 Million | 151.4 Million | - | 84.7 Million |
| Other Expenses | - | 800 Thousand | 1.8 Million | -600 Thousand | -14 Million | -4.9 Million |
| Cost and Expenses | 340.7 Million | 395 Million | 321.4 Million | 354.6 Million | 1.14 Billion | 282.4 Million |
| Operating Income | 343.1 Million | 319.9 Million | 356.3 Million | 260.1 Million | 1.18 Billion | 327 Million |
| Interest Expense | 10.1 Million | 11.6 Million | 13.3 Million | 15.1 Million | 59.3 Million | 15.6 Million |
| Income Tax Expense | 79.5 Million | 77.2 Million | 92 Million | 78.3 Million | 289.5 Million | 84.2 Million |
| Earnings before Tax | 388.6 Million | 355.3 Million | 398.6 Million | 295.4 Million | 1.27 Billion | 351.8 Million |
| Net Income | 309.1 Million | 278.1 Million | 306.6 Million | 217.1 Million | 984.8 Million | 267.6 Million |
| Earnings Per Share Basic | 6.93 | 6.26 | 6.52 | 4.62 | - | 5.71 |
| Earnings Per Share Diluted | 6.39 | 5.85 | 6.17 | 4.36 | - | 5.38 |
| Weighted Average Shares Outstanding | 44.6 Million | 44.4 Million | 47 Million | 47 Million | 46.8 Million | 46.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 48.4 Million | 47.5 Million | 49.7 Million | 49.8 Million | 49.7 Million | 49.7 Million |
| Gross Margin | 0.89 | 0.89 | 0.89 | 0.88 | 0.89 | 0.88 |
| EBIT Margin | 0.56 | 0.47 | 0.63 | 0.53 | - | 0.60 |
| Profit Margin | 0.41 | 0.39 | 0.45 | 0.35 | 0.42 | 0.44 |
| EBITDA | 417.8 Million | 338.6 Million | 426.9 Million | 324.2 Million | - | 367.4 Million |
| Earnings Before Tax Margin | 0.46 | 0.45 | 0.53 | 0.42 | 0.51 | 0.54 |
EDTK
WESTLIFE
USDR
6185
SRU-UN
PYRAMID